Steve E. Krognes

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Burlingame, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Saia, as attorney-in-fact for Steve Krognes
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steve E. Krognes

Form 4 holding Director

PLIANT THERAPEUTICS, INC.

Security class
Common Stock (Right to Buy)
Shares / value
30,000
Estimated value
$111,338
Report date
05 Jun 2025
Price
$2.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Guardant Health, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$98,318
Report date
30 Jun 2026
Price
$42.47
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Gritstone bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
51,800
Estimated value
Report date
16 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Guardant Health, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
6,833
Estimated value
Report date
18 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Steve E. Krognes

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .